TUHURA BIOSCIENCES INC
HURANASDAQ🏆 #2972 by market capUS Equity
$1,012.57▲ $75.84 (+7.49%)
Simulated price1h—
24h▲ 7.5%
7d▲ 47662.7%
14d▲ 49414.4%
30d▲ 41915.4%
1y▲ 30960.4%
🏦Market Cap
$137M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
64
Fair
Trading Snapshot
- Day Range
- $1,006.46 – $1,025.54
- 52-Week Range
- $0.41 – $3.90
- Volume
- $2.35B
- Avg Volume
- $3.04B
- Shares Outstanding
- 63.7M
- Next Earnings
- Sep 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $20M
- Last Q Revenue
- $5M
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-0.61
- Dividend Yield
- 0.01%
Why Investors Own HURA
- ✓High-growth profile — revenue up +21.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 49% gross margin and 7% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$20M▲ +15.7% YoY
Gross Margin (TTM)
49.4%▲ +4.3% YoY
Operating Income (TTM)
$7M▲ +15.7% YoY
Free Cash Flow (TTM)
$1M▲ +15.7% YoY
About TUHURA BIOSCIENCES INC
A company profile for TUHURA BIOSCIENCES INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
64/100
Analyst Price Target
ⓘAverage Target
$1,084.53
▲ +7.1% Upside
High Target$1,310.42
Low Target$958.15
Based on 38 analysts
Latest News & Updates
🚀
CNBC·2h ago
TUHURA BIOSCIENCES INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift HURA price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
TUHURA BIOSCIENCES INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.